Prolactin Deficiency in Pseudohypoparathyroidism

New England Journal of Medicine

Volumn 296, Issue 3, 1977, Pages 140-144

  Carlson, Harold E ^a   Brickman, Arnold S ^a   Bottazzo, Gian Franco ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; DIETHYLSTILBESTROL; PROLACTIN; PROTIRELIN; RADIOISOTOPE;

ADENOHYPOPHYSIS; AUTOIMMUNITY; DIAGNOSIS; ETIOLOGY; IN VITRO STUDY; MAJOR CLINICAL STUDY; PSEUDOHYPOPARATHYROIDISM; THEORETICAL STUDY;

EID: 0017349890     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197701202960304     Document Type: Article

References (29)

1. Presented in part at the annual meeting of the Endocrine Society, San Francisco, CA, June, 1976.
2. Turner RW, Takamura T: Pseudohypoparathyroidism and hypothyroidism. Ann Intern Med 56: 276–281, 1962
3. Zisman E, Lotz M, Jenkins ME: Studies in pseudohypoparathyroidism: two new cases with a probable selective deficiency of thyrotropin. Am J Med 46: 464–471, 1969
4. Marx SJ, Hershman JM, Aurbach GD: Thyroid dysfunction in pseudohypoparathyroidism. J Clin Endocrinol Metab 33: 822–828, 1971
5. Chase LR, Melson GL, Aurbach GD: Pseudohypoparathyroidism: defective excretion of 3′,5′-AMP in response to parathyroid hormone. J Clin Invest 48: 1832–1844, 1969
6. Reinhart R, Brickman AS, Kurokawa K, et al: Studies in three generations of a kindred with pseudohypoparathyroidism. Clin Res 21: 255, 1973
7. Rodriguez HJ, Villarreal H Jr, Klahr S, et al: Pseudohypoparathyroidism Type II: restoration of normal renal responsiveness to parathyroid hormone by calcium administration. J Clin Endocrinol Metab 39: 693–701, 1974
8. Woo J, Singer FR: Radioimmunoassay for human parathyroid hormone. Clin Chim Acta 54: 161–168, 1974
9. Hershman JM: Clinical application of thyrotropin-releasing hormone. N Engl J Med 290: 886–890, 1974
10. Friesen H, Guyda H, Hwang P, et al: Functional evaluation of prolactin secretion: a guide to therapy. J Clin Invest 51: 706–709, 1972
11. Eddy RL, Gilliland P, Ibarra JD Jr, et al: Human growth hormone release: comparison of provocative test procedures. Am J Med 56: 179–185, 1974
12. Jubiz W, Meikle AW, West CD, et al: Single-dose metyrapone test. Arch Intern Med 125: 472–474, 1970
13. Hashimoto T, Miyai K, Izumi K, et al: Gonadotropin response to synthetic LH-RH in normal subjects: correlation between LH and FSH. J Clin Endocrinol Metab 37: 910–916, 1973
14. Pekary AE, Hershman JM, Parlow AF: A sensitive and precise radioimmunoassay for human thyroid-stimulating hormone. J Clin Endocrinol Metab 41: 676–684, 1975
15. Sinha YN, Selby FW, Lewis UJ, et al: A homologous radioimmunoassay for human prolactin. J Clin Endocrinol Metab 36: 509–516, 1973
16. Schalch DS, Parker M.L.: A sensitive double antibody immunoassay for human growth hormone in plasma. Nature 203: 1141–1142, 1964
17. Mattingly D: A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J Clin Pathol 15: 374–379, 1962
18. Meikle AW, Jubiz W, Hutchings MP, et al: A simplified metyrapone test with determination of plasma 11-deoxycortisol (metyrapone test with plasma S). J Clin Endocrinol Metab 29: 985–987, 1969
19. Roitt IM, Doniach D: World Health Organization Manual for Autoimmune Serology. Geneva, World Health Organization, 1969
20. Bottazzo GF, Pouplard A, Florin-Christensen A, et al: Autoantibodies to prolactin-secreting cells of human pituitary. Lancet 2: 97–101, 1975
21. Ardeman S, Chanarin I: A method for the assay of human gastric intrinsic factor and for the detection and titration of antibodies against intrinsic factor. Lancet 2: 1350–1354, 1963
22. Turkington RW: Phenothiazine stimulation test for prolactin reserve: the syndrome of isolated prolactin deficiency. J Clin Endocrinol Metab 34: 247–249, 1972
23. Copinschi G, L'Hermite M, Leclercq R, et al: Effects of glucocorticoids on pituitary hormonal responses to hypoglycemia: inhibition of prolactin release. J Clin Endocrinol Metab 40: 442–449, 1975
24. Carlson HE, Jacobs LS, Daughaday WH: Growth hormone, thyrotropin and prolactin response to thyrotropin-releasing hormone following diethylstilbestrol pretreatment. J Clin Endocrinol Metab 37: 488–490, 1973
25. Yasuda K, Hurukawa Y, Okuyama M, et al: Glucose tolerance and insulin secretion in patients with parathyroid disorders: effect of serum calcium on insulin release. N Engl J Med 292: 501–504, 1975
26. Fingerhut M, Krieger DT: Plasma growth hormone response to L-dopa in obese subjects. Metabolism 23: 267–271, 1974
27. Dannies PS, Gautvik KM, Tashjian AH Jr: A possible role of cyclic AMP in mediating the effects of thyrotropin-releasing hormone on prolactin release and on prolactin and growth hormone synthesis in pituitary cells in culture. Endocrinology 98: 1147–1159, 1976
28. Nerup J: Addison's disease: serological studies. Acta Endocrinol (Kbh) 76: 142–158, 1974
29. Flier JS, Kahn CR, Roth J, et al: Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 190: 63–65, 1975